ReviewCurrent genetics2025
Possible regulatory network and associated pathways governing the expression of ADH2 in Saccharomyces cerevisiae.
Review in Current genetics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
With the day to day increase in energy consumption due to increase in urbanization production of bioethanol is highly in demand. At this point where the traditional methods are not able to suffice the demands due to its high cost and low productivity, new methods need to be developed. This review aims to understand the importance and the regulation of ADH2 in Saccharomyces cerevisiae because Adh2p is the only enzyme that initiates the reaction for the conversion of ethanol, the end product of fermentation to acetaldehyde. The effect of glucose on regulatory mechanisms of Alcohol dehydrogenase II (ADH2) with respect to Snf1 kinase, Target of Rapamycin (TOR) and CCR4 (Carbon Catabolite Repression) pathway on S. cerevisiae are discussed. Snf1 is a serine threonine kinase which is inactive in presence of high glucose concentrations and gets activated in low glucose environments which in turn affects the transcription of ADH2 by controlling the upstream TFs (Transcription Factors). TOR pathway is an essential signalling network that senses the availability of nutrients, mostly glucose and amino acids. This gets activated in presence of glucose. TORC1 regulates the transcription of ADH2 via various downstream transcription factors like Sch9p, Rim15, etc. Another global transcription factor CCR4, regulates ADH2 by acting directly upon its promoter region. The unique function of Adh2p in yeast metabolism, has directed numerous research work making it a vital target. Genetic manipulation of ADH2 gene has proved to be beneficial for food, bioethanol industry.
Indexed as
Identifiers
40824391What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.